These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3114087)

  • 1. Surface immunoglobulin intensivity and p67 (CD5) antigen expression define different forms of B-cell chronic lymphocytic leukaemia.
    Bassan R; Pronesti M; Buzzetti M; Viero P; Minetti B; Comotti B; Buelli M; Barbui T
    Haematologica; 1987; 72(3):221-5. PubMed ID: 3114087
    [No Abstract]   [Full Text] [Related]  

  • 2. [2 phenotypic variants of B-cell lymphocytic leukemia].
    Merson AG; Brosh'e Zh; Gipsh NM; Karminskaia NM; Udris OIu
    Eksp Onkol; 1988; 10(1):40-3. PubMed ID: 3259500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface phenotype and clinical stages in B-cell chronic lymphocytic leukaemia.
    Orfao A; Gonzalez M; San Miguel JF; Moro MJ; Fernandez-Calvo J; Carnero M; Galindo P; Lopez Borrasca A
    Haematologica; 1987; 72(1):39-43. PubMed ID: 3108093
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia.
    Greaves M; Verbi W; Vogler L; Cooper M; Ellis R; Ganeshaguru K; Hoffbrand V; Janossy G; Bollum FJ
    Leuk Res; 1979; 3(6):353-62. PubMed ID: 317656
    [No Abstract]   [Full Text] [Related]  

  • 6. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells.
    Bergui L; Tesio L; Schena M; Riva M; Malavasi F; Schulz T; Marchisio PC; Caligaris-Cappio F
    Eur J Immunol; 1988 Jan; 18(1):89-96. PubMed ID: 3278912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in the expression of the leucocyte-common antigen in chronic lymphocytic leukaemia.
    Smith SK; Brown VA; Dewar AE; Stockdill G; Cohen B; Maddy AH
    Clin Exp Immunol; 1985 Jan; 59(1):55-63. PubMed ID: 3156016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclasses on the lymphocyte surface in chronic lymphocytic leukemia (CLL).
    Kimby E; Hammarström L; Björkholm M; Smith E; Mellstedt H
    Haematologica; 1985; 70(1):75-7. PubMed ID: 3924762
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
    Rak K; Pecze K; Kiss A; Telek B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological definition of leukemic cell surface phenotypes.
    Melvin SL
    Cancer Res; 1981 Nov; 41(11 Pt 2):4790-3. PubMed ID: 6975161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.
    Brown VA; Smith SK; Dewar AE; Stockdill G; Maddy AH
    Clin Exp Immunol; 1985 Oct; 62(1):95-103. PubMed ID: 3877584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
    Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
    Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between different cell surface markers in chronic lymphocytic leukemia.
    Potomski J; Harłozińska A; Becker M; Noworolska A
    Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophoresis of lymphocytes from normal human subjects and patients with chronic lymphocytic leukaemia.
    Goldstone AH; Urbaniak SJ; Irvine WJ
    Clin Exp Immunol; 1974 May; 17(1):113-20. PubMed ID: 4549566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical perspective on cell markers in acute lymphocytic leukemia.
    Bowman WP; Melvin SL; Aur RJ; Mauer AM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant interaction of B-cell lymphocytic leukemia cells with antibody coated polyacrylamide beads.
    Cohen HJ
    Exp Hematol; 1983 Feb; 11(2):162-8. PubMed ID: 6601025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane phenotypic studies in B cell lymphoproliferative disorders.
    Scott CS; Limbert HJ; MacKarill ID; Roberts BE
    J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation by chemotherapy of T-cell antigen expression in B-cell chronic lymphocytic leukemia.
    Perl A; Szigeti A; Gergely P; Feher J; Magyarosi E; Sellyei M
    N Engl J Med; 1986 Jan; 314(3):186-7. PubMed ID: 2417119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.